Dr. Arijit Patra is a Senior Principal Scientist at UCB Biopharma UK, where he focuses on building a new generation of AI systems for drug safety workflows for rare diseases. Previously, he was also associated with AstraZeneca, where he contributed to several initiatives pertinent to the development of novel therapeutic candidates. He holds a PhD in machine learning for obstetric ultrasound from the University of Oxford, where he was a Rhodes Scholar. Prior to that, he completed a first degree in Mechanical Engineering from the Indian Institute of Technology (IIT) at Kharagpur, India. He has also been associated with a diverse range of projects at Shell, Microsoft Research and CSIR-South Africa and has been actively involved in the AI4SG (AI for Social Good) community. He has authored several publications around machine learning and medical imaging and has delivered multiple invited talks around the theme of Artificial Intelligence for Healthcare around the globe.